ORBIMED ADVISORS LLC

Position in MDXH — MDxHealth SA

CIK 1055951 New York, NY

Back to MDXH Full portfolio

Position in MDXH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$0

New position

Shares Held

0

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Derivatives in MDXH

reported options exposure · as of Mar 31, 2026

CallValue

$285,903,800

CallShares

124,306,000

PutValue

$0

PutShares

0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

ORBIMED ADVISORS LLC holds $728,348,629 across 5 Diagnostics & Research names.

#	Ticker	Company	Shares	Value (USD)
1	MYGN	Myriad Genetics Inc	125,000,000	$562,500,000
2	NTRA	Natera, Inc.	262,000	$52,397,380
3	DHR	Danaher Corp /De/	265,800	$50,395,680
4	GH	Guardant Health, Inc.	435,200	$40,199,424
5	TMO	Thermo Fisher Scientific Inc.	46,500	$22,856,145

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$285,903,800	124,306,000	—	Call	Sole	2026-05-15
No filing history on record for this holder in this stock.

ORBIMED ADVISORS LLC

Position in MDXH

Derivatives in MDXH

Position in Diagnostics & Research

All Filings in MDXH